Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost 0.03% in latanoprost low-responders
NCT00347841Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bimatoprost in Open-angle glaucoma (OAG) and ocular hypertension, sponsored by Janssen Pharmaceutical. Primary endpoint: Intraocular Pressure. Status: completed.
02
Drugs
bimatoprost
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00347841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347841.